Fuster, Daniel G.

Bargagli, Matteo; Trelle, Sven; Bonny, Olivier; Fuster, Daniel G. (2024). Thiazides for kidney stone recurrence prevention. Current Opinion in Nephrology & Hypertension, 33(4), pp. 427-432. Wolters Kluwer Health 10.1097/MNH.0000000000000990

Bargagli, Matteo; Anderegg, Manuel A.; Fuster, Daniel G. (2024). Effects of thiazides and new findings on kidney stones and dysglycemic side effects. Acta physiologica Wiley 10.1111/apha.14155

Dhayat, Nasser A.; Mattmann, Cédric; Seeger, Harald; Ritter, Alexander; Ernandez, Thomas; Stoermann-Chopard, Catherine; Buchkremer, Florian; Segerer, Stephan; Roth, Beat; Wuerzner, Gregoire; Wagner, Carsten A.; Bonny, Olivier; Popp, Albrecht W.; Vogt, Bruno; Bargagli, Matteo; Fuster, Daniel G. (2024). The Vitamin D metabolite diagnostic ratio associates with phenotypic traits of idiopathic hypercalciuria. Kidney international reports, 9(4), pp. 1072-1082. Elsevier 10.1016/j.ekir.2024.01.004

Anderegg, Manuel A.; Olinger, Eric G.; Bargagli, Matteo; Geraghty, Rob; Pohlmeier, Lea; Nater, Alexander; Bruggmann, Rémy; Sayer, John A.; Vogt, Bruno; Schaller, André; Fuster, Daniel G. (27 July 2023). Prevalence and characteristics of monogenic disease in adult kidney stone formers (medRxiv). Cold Spring Harbor Laboratory 10.1101/2023.07.23.23292924

Kucharczyk, Patrycja; Albano, Giuseppe; Deisl, Christine; Ho, Manh Tin; Bargagli, Matteo; Anderegg, Manuel; Wueest, Stephan; Konrad, Daniel; Fuster, Daniel G. (2023). Thiazides Attenuate Insulin Secretion Through Inhibition of Mitochondrial Carbonic Anhydrase 5b in β-islet Cells in Mice. Journal of the American Society of Nephrology JASN, 34(7), pp. 1179-1190. American Society of Nephrology 10.1681/ASN.0000000000000122

Ho, Manh Tin; Berger, Stephan; Müller, Philipp; Simonin, Céline; Reymond, Jean-Louis; von Ballmoos, Christoph; Fuster, Daniel G. (21 December 2022). Physiological and Molecular Function of the Sodium/Hydrogen Exchanger NHA2 (SLC9B2). CHIMIA, 76(12), pp. 1019-1024. Swiss Chemical Society 10.2533/chimia.2022.1019

Olinger, Eric; Schaeffer, Céline; Kidd, Kendrah; Elhassan, Elhussein A. E.; Cheng, Yurong; Dufour, Inès; Schiano, Guglielmo; Mabillard, Holly; Pasqualetto, Elena; Hofmann, Patrick; Fuster, Daniel G.; Kistler, Andreas D.; Wilson, Ian J.; Kmoch, Stanislav; Raymond, Laure; Robert, Thomas; Eckardt, Kai-Uwe; Bleyer, Anthony J.; Köttgen, Anna; Conlon, Peter J.; ... (2022). An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 119(33), e2114734119. National Academy of Sciences NAS 10.1073/pnas.2114734119

Moor, Matthias B.; Dhayat, Nasser A.; Schietzel, Simeon; Grössl, Michael; Vogt, Bruno; Fuster, Daniel G. (2022). Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers. Urolithiasis, 50(3), pp. 333-340. Springer 10.1007/s00240-022-01317-2

Fuster, Daniel G.; Morard, Gaétan; Schneider, Lisa; Mattmann, Cedric; Lüthi, David; Vogt, Bruno; Dhayat, Nasser A. (2022). Association of urinary sex steroid hormones with urinary calcium, oxalate and citrate excretion in kidney stone formers. Nephrology, dialysis, transplantation, 37(2), pp. 335-348. Oxford University Press 10.1093/ndt/gfaa360

Dhayat, Nasser A.; Schneider, Lisa; Popp, Albrecht W.; Lüthi, David; Mattmann, Cedric; Vogt, Bruno; Fuster, Daniel G. (2022). Predictors of Bone Mineral Density in Kidney Stone Formers. Kidney international reports, 7(3), pp. 558-567. Elsevier 10.1016/j.ekir.2021.12.003

Schietzel, Simeon; Moor, Matthias B.; Fuster, Daniel G. (2021). Severe hypomagnesemia. Journal of nephrology JN, 34(6), pp. 2123-2126. Springer 10.1007/s40620-021-01001-5

Schnyder, Daniela; Albano, Giuseppe; Kucharczyk, Patrycja; Dolder, Silvia; Siegrist, Mark; Anderegg, Manuel; Pathare, Ganesh; Hofstetter, Wilhelm; Baron, Roland; Fuster, Daniel G. (2021). Deletion of the sodium/hydrogen exchanger 6 causes low bone volume in adult mice. Bone, 153, p. 116178. Elsevier 10.1016/j.bone.2021.116178

Verouti, Sophia N; Lambert, Delphine; Mathis, Déborah; Pathare, Ganesh; Escher, Geneviève; Vogt, Bruno; Fuster, Daniel G. (2021). The solute carrier SLC16A12 is critical for creatine and guanidinoacetate handling in the kidney. American journal of physiology. Renal physiology, 320(3), F351-F358. American Physiological Society 10.1152/ajprenal.00475.2020

Williams, James C; Gambaro, Giovanni; Rodgers, Allen; Asplin, John; Bonny, Olivier; Costa-Bauzá, Antonia; Ferraro, Pietro Manuel; Fogazzi, Giovanni; Fuster, Daniel G.; Goldfarb, David S; Grases, Félix; Heilberg, Ita P; Kok, Dik; Letavernier, Emmanuel; Lippi, Giuseppe; Marangella, Martino; Nouvenne, Antonio; Petrarulo, Michele; Siener, Roswitha; Tiselius, Hans-Göran; ... (2021). Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis, 49(1), pp. 1-16. Springer 10.1007/s00240-020-01217-3

Anderegg, Manuel A.; Albano, Giuseppe; Hanke, Daniela; Deisl, Christine; Uehlinger, Dominik E.; Brandt, Simone; Bhardwaj, Rajesh; Hediger, Matthias A.; Fuster, Daniel G. (2021). The sodium/proton exchanger NHA2 regulates blood pressure through a WNK4-NCC dependent pathway in the kidney. Kidney international, 99(2), pp. 350-363. Elsevier 10.1016/j.kint.2020.08.023

Garrelfs, Sander F.; Frishberg, Yaacov; Hulton, Sally A.; Koren, Michael J.; O’Riordan, William D.; Cochat, Pierre; Deschênes, Georges; Shasha-Lavsky, Hadas; Saland, Jeffrey M.; van’t Hoff, William G.; Fuster, Daniel G.; Magen, Daniella; Moochhala, Shabbir H.; Schalk, Gesa; Simkova, Eva; Groothoff, Jaap W.; Sas, David J.; Meliambro, Kristin A.; Lu, Jiandong; Sweetser, Marianne T.; ... (2021). Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. New England journal of medicine NEJM, 384(13), pp. 1216-1226. Massachusetts Medical Society MMS 10.1056/NEJMoa2021712

Fuster, Daniel G. (2021). Metaphylaxe von Nierensteinen mittels medikamentöser und diätetischer Massnahmen. Therapeutische Umschau, 78(5), pp. 241-246. Huber 10.1024/0040-5930/a001267

Harmacek, Dusan; Becker, Daniel; Bühlmann, Roman; Lyttwin, Benjamin; Fuster, Daniel G. (2021). Ungewöhnliche Ursache einer ausgeprägten Proteinurie. Swiss medical forum, 21(27–28), pp. 491-494. EMH Schweizerischer Ärzteverlag AG 10.4414/smf.2021.08658

Augustynek, Bartlomiej; Gyimesi, Gergely; Dernic, Jan; Sallinger, Matthias; Albano, Giuseppe; Klesse, Gabriel J.; Kandasamy, Palanivel; Grabmayr, Herwig; Frischauf, Irene; Fuster, Daniel G.; Peinelt, Christine; Hediger, Matthias A.; Bhardwaj, Rajesh (2021). Dissecting gating mechanisms of Orai calcium channel paralogs using constitutively active Orai mutants that mimic STIM1-gated state (In Press) (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2021.10.26.465861

Tsaturyan, Arman; Bokova, Elizaveta; Bosshard, Piet; Bonny, Olivier; Fuster, Daniel G.; Roth, Beat (2020). Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content. Urolithiasis, 48(6), pp. 501-507. Springer 10.1007/s00240-020-01204-8

Bargagli, Matteo; Dhayat, Nasser A.; Anderegg, Manuel; Semmo, Mariam; Huynh-Do, Uyen; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G. (2020). Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan. Clinical Journal of the American Society of Nephrology, 15(7), pp. 1007-1014. American Society of Nephrology 10.2215/CJN.13861119

Dhayat, Nasser A.; Pruijm, Menno; Ponte, Belen; Ackermann, Daniel; Leichtle, Alexander Benedikt; Devuyst, Olivier; Ehret, Georg; Guessous, Idris; Pechère-Bertschi, Antoinette; Pastor, Johanne; Martin, Pierre-Yves; Burnier, Michel; Fiedler, Georg-Martin; Vogt, Bruno; Moe, Orson; Bochud, Murielle; Fuster, Daniel G. (2020). Parathyroid hormone and plasma phosphate are predictors of soluble α-klotho levels in adults of European descent. The journal of clinical endocrinology and metabolism, 105(4), e1135-e1143. Oxford University Press 10.1210/clinem/dgz232

Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Giménez, Jonai (2020). Correction: Unraveling the structural elements of pH sensitivity and substrate binding in the human zinc transporter SLC39A2 (ZIP2). Journal of biological chemistry, 295(13), p. 4369. American Society for Biochemistry and Molecular Biology 10.1074/jbc.AAC120.013245

Kucharava, Krystsina; Brand, Yves; Albano, Giuseppe; Sekulic-Jablanovic, Marijana; Glutz, Andrea; Xian, Xunde; Herz, Joachim; Bodmer, Daniel; Fuster, Daniel G.; Petkovic, Vesna (2020). Sodium-hydrogen exchanger 6 (NHE6) deficiency leads to hearing loss, via reduced endosomal signalling through the BDNF/Trk pathway. Scientific reports, 10(1), p. 3609. Springer Nature 10.1038/s41598-020-60262-5

Anderegg, Manuel A.; Dhayat, Nasser A.; Sommer, Grit; Semmo, Mariam; Huynh-Do, Uyen; Vogt, Bruno; Fuster, Daniel G. (2020). Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan. Kidney medicine, 2(2), pp. 162-171. Elsevier 10.1016/j.xkme.2019.11.008

Fuster, Daniel G.; Moe, Orson W (2018). Incomplete Distal Renal Tubular Acidosis and Kidney Stones. Advances in chronic kidney disease, 25(4), pp. 366-374. Elsevier 10.1053/j.ackd.2018.05.007

Alexander, R Todd; McArthur, Eric; Jandoc, Racquel; Welk, Blayne; Fuster, Daniel G.; Garg, Amit X; Quinn, Robert R (2018). Thiazide Diuretic Dose and Risk of Kidney Stones in Older Adults: A Retrospective Cohort Study. Canadian journal of kidney health and disease, 5, p. 2054358118787480. Sage 10.1177/2054358118787480